Mechanism of escherichia coli resistance to pyrrhocoricin

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 5, 2014, Pages 2754-2762

  Narayanan, Shalini ^a   Modak, Joyanta K ^a   Ryan, Catherine S ^a   Garcia Bustos, Jose ^a   Davies, John K ^a   Roujeinikova, Anna ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; OUTER MEMBRANE PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; PYRRHOCORICIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; INSECT PROTEIN; PYRRHOCORICIN PROTEIN, PYRRHOCORIS APTERUS;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BROTH DILUTION; CELL MEMBRANE PERMEABILITY; DROSOPHILA MELANOGASTER; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE DISRUPTION; GENE SEQUENCE; GRAM NEGATIVE BACTERIUM; HETEROLOGOUS EXPRESSION; HIGH THROUGHPUT SEQUENCING; IN VITRO SELECTION; MAMMAL CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; WILD TYPE; DRUG EFFECTS;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; ESCHERICHIA COLI; INSECT PROTEINS;

EID: 84898611985     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02565-13     Document Type: Article

References (55)

1. Centers for Disease Control and Prevention (CDC). 2013. Antibiotic resistance threats in the United States, 2013. CDC, Atlanta, GA. http://www.cdc.gov/drugresistance/threat-report-2013.
2. Hancock REW. 2007. The end of an era. Nat. Rev. Drug Discov. 6:28. http://dx.doi.org/10.1038/nrd2223.
3. Ho J, Tambyah PA, Paterson DL. 2010. Multiresistant Gram-negative infections: a global perspective. Curr. Opin. Infect. Dis. 23:546-553. http://dx.doi.org/10.1097/QCO.0b013e32833f0d3e.
4. Scocchi M, Tossi A, Gennaro R. 2011. Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action. Cell. Mol. Life Sci. 68:2317-2330. http://dx.doi.org/10.1007/s00018-011-0721-7.
5. Otvos L, Jr. 2002. The short proline-rich antibacterial peptide family. Cell. Mol. Life Sci. 59:1138-1150. http://dx.doi.org/10.1007/s00018-002-8493-8.
6. Gennaro R, Zanetti M, Benincasa M, Podda E, Miani M. 2002. Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of action. Curr. Pharm. Des. 8:763-778. http://dx.doi.org/10.2174/ 1381612023395394.
7. Bulet P, Hetru C, Dimarcq JL, Hoffmann D. 1999. Antimicrobial peptides in insects; structure and function. Dev. Comp. Immunol. 23:329- 344. http://dx.doi.org/10.1016/S0145-305X(99)00015-4.
8. Cudic M, Condie BA, Weiner DJ, Lysenko ES, Xiang ZQ, Insug O, Bulet P, Otvos L, Jr. 2002. Development of novel antibacterial peptides that kill resistant isolates. Peptides 23:2071-2083. http://dx.doi.org/10.1016/S0196- 9781(02)00244-9.
9. Otvos L, Jr, Bokonyi K, Varga I, Otvos BI, Hoffmann R, Ertl HC, Wade JD, McManus AM, Craik DJ, Bulet P. 2000. Insect peptides with improved protease-resistance protect mice against bacterial infection. Protein Sci. 9:742-749.
10. Casteels P, Ampe C, Jacobs F, Vaeck M, Tempst P. 1989. Apidaecins: antibacterial peptides from honeybees. EMBO J. 8:2387-2391.
11. Bulet P, Dimarcq JL, Hetru C, Lagueux M, Charlet M, Hegy G, Van Dorsselaer A, Hoffmann JA. 1993. A novel inducible antibacterial peptide of Drosophila carries an O-glycosylated substitution. J. Biol. Chem. 268:14893-14897.
12. Cociancich S, Dupont A, Hegy G, Lanot R, Holder F, Hetru C, Hoffmann JA, Bulet P. 1994. Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocoris apterus. Biochem. J. 300:567-575.
13. Bulet P, Urge L, Ohresser S, Hetru C, Otvos L, Jr. 1996. Enlarged scale chemical synthesis and range of activity of drosocin, an O-glycosylated antibacterial peptide from Drosophila. Eur. J. Biochem. 238:64-69. http://dx.doi.org/10.1111/j.1432-1033.1996.0064q.x.
14. Kragol G, Lovas S, Varadi G, Condie BA, Hoffmann R, Otvos L, Jr. 2001. The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-Assisted protein folding. Biochemistry 40:3016-3026. http://dx.doi.org/10.1021/bi002656a.
15. Liebscher M, Roujeinikova A. 2009. Allosteric coupling between lid and interdomain linker in DnaK revealed by inhibitor binding studies. J. Bacteriol. 191:1456-1462. http://dx.doi.org/10.1128/JB.01131-08.
16. Scocchi M, Lüthy C, Decarli P, Mignogna G, Christen P, Gennaro R. 2009. The proline-rich antibacterial peptide Bac7 binds to and inhibits in vitro the molecular chaperone DnaK. Int. J. Pept. Res. Therapeut. 15:147- 155. http://dx.doi.org/10.1007/s10989-009-9182-3.
17. Czihal P, Knappe D, Fritsche S, Zahn M, Berthold N, Piantavigna S, Müller U, van Dorpe S, Herth N, Binas A, Köhler G, de Spiegeleer B, Martin LL, Nolte O, Sträter N, Alber G, Hoffmann R. 2012. Api88 is a novel antibacterial designer peptide to treat systemic infections with multidrug- resistant Gram-negative pathogens. ACS Chem. Biol. 7:1281- 1291. http://dx.doi.org/10.1021/cb300063v.
18. Otvos L, Jr, Rogers ME, Consolvo PJ, Condie BA, Lovas S, Bulet P, Blaszczyk-Thurin M. 2000. Interaction between heat shock proteins and antimicrobial peptides. Biochemistry 39:14150-14159. http://dx.doi.org/10.1021/ bi0012843.
19. Zhou YS, Chen WN. 2011. iTRAQ-coupled 2-D LC-MS/MS analysis of cytoplasmic protein profile in Escherichia coli incubated with apidaecin IB. J. Proteomics 75:511-516. http://dx.doi.org/10.1016/j.jprot.2011.08.015.
20. Otvos L, Jr, Wade JD, Lin F, Condie BA, Hanrieder J, Hoffmann R. 2005. Designer antibacterial peptides kill fluoroquinolone-resistant clinical isolates. J. Med. Chem. 48:5349-5359. http://dx.doi.org/10.1021/jm050347i.
21. Knappe D, Piantavigna S, Hansen A, Mechler A, Binas A, Nolte O, Martin LL, Hoffmann R. 2010. Oncocin (VDKPPYLPRPRPPRRIYNRNH2): a novel antibacterial peptide optimized against Gram-negative human pathogens. J. Med. Chem. 53:5240-5247. http://dx.doi.org/10.1021/jm100378b.
22. Appleyard RK. 1954. Segregation of new lysogenic types during growth of a doubly lysogenic strain derived from Escherichia coli K-12. Genetics 39: 440-452.
23. Amsterdam D. 1996. Susceptibility testing of antimicrobials in liquid media, p 52-111. In Lorian V (ed), Antibiotics in laboratory medicine, 4th ed. Williams & Wilkins, Baltimore, MD.
24. Chromek M, Slamová Z, Bergman P, Kovács L, Podracká L, Ehrén I, Hökfelt T, Gudmundsson GH, Gallo RL, Agerberth B, Brauner A. 2006. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12:636-641. http://dx.doi.org/10.1038/nm1407.
25. Cudic M, Lockatell CV, Johnson DE, Otvos L, Jr. 2003. In vitro and in vivo activity of an antibacterial peptide analog against uropathogens. Peptides 24:807-820. http://dx.doi.org/10.1016/S0196-9781(03)00172-4.
26. Hayashi K, Morooka N, Yamamoto Y, Fujita K, Isono K, Choi S, Ohtsubo E, Baba T, Wanner BL, Mori H, Horiuchi T. 2006. Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110. Mol. Syst. Biol. http://dx.doi.org/10.1038/msb4100049.
27. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23:2947-2948. http://dx.doi.org/10.1093/bioinformatics/btm404.
28. Bradford MM. 1976. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal.Biochem.72:248-254.http://dx.doi.org/10.1016/0003-2697 (76)90527-3.
29. Henderson TA, Young KD, Denome SA, Elf PK. 1997. AmpC and AmpH, proteins related to the class C beta-lactamases, bind penicillin and contribute to the normal morphology of Escherichia coli. J. Bacteriol. 179: 6112-6121.
30. Gonzalez-Leiza SM, de Pedro MA, Ayala JA. 2011. AmpH, a bifunctional DD-endopeptidase and DD-carboxypeptidase of Escherichia coli. J. Bacteriol. 193:6887-6894. http://dx.doi.org/10.1128/JB.05764-11.
31. Laviña M, Pugsley AP, Moreno F. 1986. Identification, mapping, cloning and characterization of a gene (sbmA) required for microcin B17 action on Escherichia coli K-12. J. Gen. Microbiol. 132:1685-1693.
32. Runti G, Del Carmen Lopez Ruiz M, Stoilova T, Hussain R, Jennions M, Choudhury HG, Benincasa M, Gennaro R, Beis K, Scocchi M. 2013. Functional characterization of SbmA, a bacterial inner membrane transporter required for importing the antimicrobial peptide Bac7(1-35). J. Bacteriol. 195:5343-5351. http://dx.doi.org/10.1128/JB.00818-13.
33. Corbalan N, Runti G, Adler C, Covaceuszach S, Ford R, Lamba D, Beis K, Scocchi M, Vincent PA. 2013. Functional and structural study of the dimeric inner membrane protein SbmA. J. Bacteriol. 195:5352-5361. http://dx.doi.org/10. 1128/JB.00824-13.
34. Mattiuzzo M, Bandiera A, Gennaro R, Benincasa M, Pacor S, Antcheva N, Scocchi M. 2007. Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides. Mol. Microbiol. 66:151-163. http://dx.doi.org/10. 1111/j.1365-2958.2007.05903.x.
35. Pränting M, Negrea A, Rhen M, Andersson DI. 2008. Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2. Antimicrob. Agents Chemother. 52:2734-2741. http://dx.doi.org/10.1128/AAC. 00205-08.
36. Rezuchova B, Miticka H, Homerova D, Roberts M, Kormanec J. 2003. New members of the Escherichia coli-E regulon identified by a twoplasmid system. FEMS Microbiol. Lett. 225:1-7. http://dx.doi.org/10.1016/S0378-1097(03)00480-4.
37. Strazewski P. 1988. Mispair formation in DNA can involve rare tautomeric forms in the template. Nucleic Acids Res. 16:9377-9398. http://dx.doi.org/10. 1093/nar/16.20.9377.
38. Topal MD, Fresco Jr. 1976. Complementary base pairing and the origin of substitution mutations. Nature 263:285-289. http://dx.doi.org/10.1038/263285a0.
39. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410. http://dx.doi.org/10.1016/ S0022-2836(05)80360-2.
40. Krebs JE, Goldstein ES, Kilpatrick ST. 2013. Transposable elements and retroviruses, p 408-440. In Lewin's essential genes, 3rd ed. Jones & Bartlett Learning, LLC, Sudbury, MA.
41. Saier MH. 2000. Families of transmembrane transporters selective for amino acids and their derivatives. Microbiology 146:1775-1795.
42. Gopinath K, Venclovas C, Ioerger TR, Sacchettini JC, McKinney JD, Mizrahi V, Warner DF. 2013. A vitamin B12 transporter in Mycobacterium tuberculosis. Open Biol. 3:120175. http://dx.doi.org/10.1098/rsob.120175.
43. Park JT, Uehara T. 2008. How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan). Microbiol. Mol. Biol. Rev. 72:211-227. http://dx.doi.org/10.1128/MMBR.00027-07.
44. Salomon RA, Farias RN. 1995. The peptide antibiotic microcin 25 is imported through the TonB pathway and the SbmA protein. J. Bacteriol. 177:3323-3325.
45. Yorgey P, Lee J, Kordel J, Vivas E, Warner P, Jebaratnam D, Kolter R. 1994. Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor. Proc. Natl. Acad. Sci. U. S. A. 91: 4519-4523. http://dx.doi.org/10.1073/pnas.91.10.4519.
46. Puckett SE, Reese KA, Mitev GM, Mullen V, Johnson RC, Pomraning KR, Mellbye BL, Tilley LD, Iversen PL, Freitag M, Geller BL. 2012. Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers. Antimicrob. Agents Chemother. 56:6147-6153. http://dx.doi.org/10.1128/AAC.00850- 12.
47. Ghosal A, Vitali A, Stach JE, Nielsen PE. 2013. Role of SbmA in the uptake of peptide nucleic acid (PNA)-peptide conjugates in E. coli. ACS Chem. Biol. 8:360-367. http://dx.doi.org/10.1021/cb300434e.
48. Li G, Laturnus C, Ewers C, Wieler LH. 2005. Identification of genes required for avian Escherichia coli septicemia by signature-tagged mutagenesis. Infect. Immun. 73:2818-2827. http://dx.doi.org/10.1128/IAI.73.5.2818-2827.2005.
49. Bencivengo AM, Cudic M, Hoffmann R, Otvos L. 2003. The efficacy of the antibacterial peptide, pyrrhocoricin, is finely regulated by its amino acid residues and active domains. Lett. Pept. Sci. 8:201-209. http://dx.doi.org/10. 1007/BF02446518.
50. Hoffmann R, Bulet P, Urge L, Otvos L, Jr. 1999. Range of activity and metabolic stability of synthetic antibacterial glycopeptides from insects. Biochim. Biophys. Acta 1426:459-467. http://dx.doi.org/10.1016/S0304-4165(98) 00169-X.
51. LeVier K, Walker GC. 2001. Genetic analysis of the Sinorhizobium meliloti BacA protein: differential effects of mutations on phenotypes. J. Bacteriol. 183:6444-6453. http://dx.doi.org/10.1128/JB.183.21.6444-6453.2001.
52. McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK. 2001. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852-856. http://dx.doi.org/10.1038/35101614.
53. Nie H, Yang F, Zhang X, Yang J, Chen L, Wang J, Xiong Z, Peng J, Sun L, Dong J, Xue Y, Xu X, Chen S, Yao Z, Shen Y, Jin Q. 2006. Complete genome sequence of Shigella flexneri 5b and comparison with Shigella flexneri 2a. BMC Genomics 7:173. http://dx.doi.org/10.1186/1471-2164-7-173.
54. Petty NK, Bulgin R, Crepin VF, Cerdeno-Tarraga AM, Schroeder GN, Quail MA, Lennard N, Corton C, Barron A, Clark L, Toribio AL, Parkhill J, Dougan G, Frankel G, Thomson NR. 2010. The Citrobacter rodentium genome sequence reveals convergent evolution with humanpathogenic Escherichia coli. J. Bacteriol. 192:525-538. http://dx.doi.org/10.1128/JB.01144-09.
55. Humann JL, Wildung M, Cheng C-H, Lee T, Drew JC, Triplett EW, Main D, Schroeder BK. 2011. Complete genome of the onion pathogen Enterobacter cloacae EcWSU1. Stand. Genomic Sci. 5:279-286. http://dx.doi.org/10.4056/sigs.2174950.